MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

Name	Symbol	Market	Type
Harbor Multi asset Explorer ETF	AMEX:MAPP	AMEX	Exchange Traded Fund

Name

Symbol

Market

Type

Harbor Multi asset Explorer ETF

AMEX:MAPP

AMEX

Exchange Traded Fund

	Price Change	% Change	Price	High Price	Low Price	Open Price	Traded	Last Trade
	-0.1463	-0.66%	22.053				0	21:15:02

Price Change

% Change

Price

High Price

Low Price

Open Price

Traded

Last Trade

-0.1463

-0.66%

22.053

21:15:02

MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

06/01/2010 12:00pm

PR Newswire (US)

Harbor Multi asset Explo... (AMEX:MAPP)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Harbor Multi asset Explo... Charts.

MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today announced that the company will present at the 28th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2010 at 9:00 a.m. PT in San Francisco. A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com/. A replay will also be available within 24 hours for seven days following the presentation. About MAP Pharmaceuticals MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX(TM) orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com/. CONTACT: Lisa Borland MAP Pharmaceuticals, Inc. (650) 386-3122 DATASOURCE: MAP Pharmaceuticals, Inc. CONTACT: Lisa Borland of MAP Pharmaceuticals, Inc., +1-650-386-3122 Web Site: http://www.mappharma.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

MAPP Harbor Multi asset Explorer ETF